NVIGEN, Inc. develops nanoparticle research reagents and devices for biomedical research applications. The company offers customized nanoparticle services and prepackaged nanoparticle reagents for industrial and academic laboratories to research for better imaging, diagnostic, and therapeutic solutions. Its products include MaxVigen, a multifunctional fluorescent magnetic nanoparticle for in vivo fluorescence, MRI, correlated fluorescence and MRI, and cancer imaging and targeting applications; and AngioGazer, a fluorescent nanoparticle for in vivo studying of angiogenesis and blood vessel maturation. The company also provides customized expert services, such as fluorescence detection and immunofluorescent imaging; in vivo studies for targeting and imaging of cancer, cardiovascular, or other diseases; delivery of research drugs or other payloads, such as antibodies, DNA, and siRNA; MRI imaging, magnetic manipulation, and targeting; research therapeutic cell labeling and monitoring; and multifunctional imaging, targeting, diagnostic, and therapeutic research.
